May 17, 2020

Medicalchain partners with the Mayo Clinic

healthcare services
Digital health
Catherine Sturman
2 min
Renowned for its high-quality patient care and known as one of the best hospitals in the US, The Mayo Clinic has partnered with UK blockchain start-up M...

Renowned for its high-quality patient care and known as one of the best hospitals in the US, The Mayo Clinic has partnered with UK blockchain start-up Medicalchain to support the development of future services.

Mayo Clinic is top ranked in a wide range of specialities, including diabetes and endocrinology, gastroenterology, geriatrics, gynaecology, nephrology, neurology and neurosurgery, pulmonology and urology.

Each year, up to 1.3mn people visit the Mayo Clinic for care, where the organisation works to improve the delivery of health care through data-driven, evidence-based care.

The clinic’s interest in blockchain will enable the two organisations to explore the benefits this could bring to medical records, providing speed, a reduction in healthcare costs, greater security and guaranteed positive patient outcomes, delivering fully connected care, rather than a fragmented, siloed response.

“We are thrilled to be working with Mayo Clinic. Mayo Clinic will provide their world-class healthcare and health IT expertise, while Medicalchain will provide our knowledge of blockchain and crypto,” said Dr Abdullah Albeyatti, CEO of Medicalchain.

See also

“Together we will work on several use cases using blockchain based electronic health records. There’s a lot of opportunity out there, and we feel this working agreement will be of benefit to all healthcare stakeholders.”

By providing the patient full access and control over their data, via mobile or desktop, they will gain the capability to provide differing levels of access to various users, assigning permissions and designating who can query and write data to their blockchain health record.

By fully owning their medical record through blockchain technology, patients will be able to ‘own’ their record, ensuring greater trust and transparency, as well as gain the ability to revoke users if required in order to ensure robust data security.

Approved clinicians will have the ability to ‘read and write’ to the patient’s records and indicate who has accessed their medical data, the time of access and the types of data that can be accessed.

Share article

Jun 22, 2021

NeuTigers: edge AI in healthcare

edgecomputing
edgeAI
AI
prediction
3 min
We take a look at edge AI and how NeuTigers is driving this forward in healthcare

What is edge AI? 

Edge AI is essentially a combination of edge computing and artificial intelligence. Algorithms are processed locally - directly on a mobile device or server - rather than in the cloud. This reduces cost, computing power and energy requirements. There are also claims that edge AI is so fast it is possible to reach near real-time analytics

Edge AI devices include smart speakers, smart phones, laptops, robots, self-driven cars, drones, and surveillance cameras that use video analytics. 

Who is NeuTigers? 

NeuTigers is a spin-off company from Princeton University, formed in 2018 to apply edge AI and machine learning to solve challenges in healthcare, energy, productivity, and security. 

With offices in Princeton, NJ, the company is based at one of the top AI accelerator programs of FutureLabs in New York, and has also established a subsidiary in Nice, France.

How is NeuTigers applying edge AI to healthcare? 

The NeuTigers AI Technology Stack uses deep  neural networks that mimic how the human brain perceives and interprets the world. The company has developed the StarDeepTM Smart Health Platform for health monitoring and biomedical imaging, to improve the accuracy and speed of diagnosing diseases. 

NeuTigers say the platform has the potential to monitor and screen for thousands of conditions,  when used in combination with medical devices and  smart sensors already deployed in healthcare settings. 

Are there any real world examples? 

In January NeuTigers launched CovidDeep, a tool that predicts COVID-19 with more than 90% accuracy, using physiological data from a wristband along with blood pressure and blood oxygen readings. It then analyses the data and gives a prediction within two minutes. 

This week NeuTigers announced a new study to detect the early signs of  complications with sickle cell anaemia.  Conducted at a hospital in Paris, the research will begin by looking at changes to skin response, heart beat, sleep and temperature to predict an acute episode of sickle cell anaemia, and how this impacts on the patients’ disease conditions and quality of life. 

The second phase of the project is to expand with prospective studies across different sites in EU, Africa  and the US to explore the models' accuracy and clinical effectiveness. 

They say...

Adel Laoui, CEO and founder of NeuTigers, says: “The best way to deal with a crisis is to avoid it happening in the first place. We are now entering a new era where medical early warning systems have become a reality. 

“We are excited at the possibility of deploying a technology that can save lives of patients dealing with sickle cell anaemia. The potential of the StarDeep platform to dramatically improve patient outcomes while slashing some of the highest costs of healthcare makes it one of the most exciting developments in preventative personal medicine.”

Share article